Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se? by Bagger, Y. Z. et al.
ORIGINAL ARTICLE
Links between cardiovascular disease and osteoporosis
in postmenopausal women: serum lipids or atherosclerosis
per se?
Y. Z. Bagger & H. B. Rasmussen & P. Alexandersen &
T. Werge & C. Christiansen & L. B. Tankó &
PERF study group
Received: 18 August 2006 /Accepted: 9 October 2006 / Published online: 16 November 2006
# International Osteoporosis Foundation and National Osteoporosis Foundation 2006
Abstract
Introduction and hypothesis Epidemiological observations
suggest links between osteoporosis and risk of acute
cardiovascular events and vice versa. Whether the two
clinical conditions are linked by common pathogenic
factors or atherosclerosis per se remains incompletely
understood. We investigated whether serum lipids and
polymorphism in the ApoE gene modifying serum lipids
could be a biological linkage.
Methods This was an observational study including 1176
elderly women 60–85 years old. Women were genotyped
for epsilon (ɛ) allelic variants of the ApoE gene, and data
concerning serum lipids (total cholesterol, triglycerides,
HDL-C, LDL-C, apoA1, ApoB, Lp(a)), hip and spine
BMD, aorta calcification (AC), radiographic vertebral
fracture and self-reported wrist and hip fractures, cardio-
vascular events together with a wide array of demographic
and lifestyle characteristics were collected.
Results Presence of the ApoE ɛ4 allele had a significant
impact on serum lipid profile, yet no association with spine/
hip BMD or AC could be established. In multiple
regression models, apoA1 was a significant independent
contributor to the variation in AC. However, none of the
lipid components were independent contributors to the var-
iationinspine orhipBMD.Whencomparingthe womenwith
or without vertebral fractures, serum triglycerides showed
significant differences. This finding was however not appli-
cable tohiporwristfractures.Afteradjustmentforage,severe
AC score (≥6) and/or manifest cardiovascular disease in-
creased the risk of hip but not vertebral or wrist fractures.
Conclusion The contribution of serum lipids to the modu-
lators of BMD does not seem to be direct but rather indirect
via promotion of atherosclerosis, which in turn can affect
bone metabolism locally, especially when skeletal sites
supplied by end-arteries are concerned. Further studies are
needed to explore the genetic or environmental risk factors
underlying the association of low triglyceride levels to
vertebral fractures.
Keywords Aortacalcification.ApoEpolymorphism.
Cardiovascularevents.Lipids.Osteoporosis
Introduction
Osteoporotic fractures and acute cardiovascular events
remain the predominant contributors to morbidity and
mortality among the elderly. Postmenopausal women with
osteoporosis are at increased risk for acute cardiovascular
events independent of their age and cardiovascular risk
profile, and the increase in risk is proportional to the
severity of osteoporosis at the time of the diagnosis [1].
Bone mineral density (BMD) at the hip is inversely
correlated with the severity of aorta calcification (AC) and
hence low hip BMD can be a surrogate marker of the
atherosclerotic burden in elderly women [2]. Large cohort
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carpals, proximal femur, and calcaneus is proportional to
the progression of AC [3–5]. Finally, advanced AC is
associated with increased risk of osteoporotic fractures [5,
6]. Collectively, numerous epidemiological observations
document an overlap between the pathogenesis of the two
diseases [7, 8].
An attractive concept is that cardiovascular disease and
osteoporosis are linked by a common denominator acting in
parallel on both vascular and bone cells [9, 10]. Plausible
candidates of such linking factors are serum lipids, which in
addition to their established role in atherogenesis, were also
shown to act on osteoblasts [11–13] and osteoclasts [14]
under experimental conditions. Although some smaller
cross-sectional studies found associations between lipid
profile and BMD in humans [15–17], neither large popula-
tion-based studies (e.g., NHANES III) nor prospective
studies support these initial observations [18, 19]. A possible
explanation the discrepancies could be that the true driver of
the association is obstructive vascular disease, meaning that
the association of lipids to bone is not detectable before the
severity of intraluminal lesions reaches a critical grade when
blood supply to the anatomical region is considerably
hampered. Until now there have been no epidemiological
studies that investigated associations of lipids and lipoprotein
components with bone independent of a direct surrogate of
the atherosclerotic burden.
The aim of the present study was to test this hypothesis
and investigate associations of a wide array of serum lipids
and lipoproteins as well as of a genetic determinant of lipid
profile with different surrogate measures of osteoporosis
(BMD, fractures) and cardiovascular disease (AC, acute
events) in 1176 Danish postmenopausal women providing
full-set of data for such analyses.
Subjects and methods
Study population
The study population consisted of 1176 generally healthy
postmenopausal women participating in the PERF study.
Details on recruiting have been described elsewhere [20].
This subpopulation was selected based on those whose
BMD and body composition were measured by the same
DXA scanner. The population characteristics were not
statistically significant from the total PERF population
indicating that the results reported herein are generally
applicable to elderly Caucasian women 60–85 years old.
None of the women received any approved antiresorptive
treatment or any other drugs with known effect on bone
mass for more than 1 year. Forty-two patients reporting
ongoing treatment with lipid-lowering drugs was excluded
when analyzing associations of allelic variation in the ApoE
gene with lipid profile.
All women gave written their informed consent to
participation and the study was carried out in compliance
with the Helsinki Declaration II and the European Stan-
dards for Good Clinical Practice. The study protocol was
approved by the local ethical committee.
Demographic characteristics, risk factors, and clinical
events
Body weight and height were measured to the closest
0.1 kg and 0.1 cm, respectively, in women wearing light
indoor clothing and no shoes. Body mass index (BMI) was
calculated as body weight (in kg) divided by height squared
(in m). Information about age, years since menopause,
smoking habits, regular alcohol and coffee consumption,
weekly exercise, prevalent diabetes and cardiovascular
diseases (stroke, coronary events, intermittent claudication,
unstable angina) were collected during personal interview
using a questionnaire [20].
Bone mineral density and fat mass measurement
Bone mineral density (BMD) of the lumbar spine L1-4 and
total hip was measured by dual energy X-ray absorptiom-
etry (DEXA) using a QDR-2000 scanner (Hologic Inc.,
Waltham, MA, USA). Daily phantom scans were per-
formed each morning for proper quality control. Body
composition also was measured by the same whole-body
scanner. The two components measured were total body fat
mass (TFM) in kilograms and total lean mass in kilograms
[21]. Total body fat mass was divided into two depots:
central fat mass (CFM, subcutaneous and visceral fat mass
of the trunk) and peripheral fat mass (PFM, subcutaneous
fat mass of the legs and arms). Body fat distribution was
expressed by the CFM/PFM ratio, analogous to the well-
known waist-to-hip ratio [22].
Fracture diagnosis
Lateral X-rays of the thoracic and lumbar spine were
performed using standard X-ray equipment. Vertebral
deformities from T4 to L4 were assessed by digital
measurements of vertebral deformations using the Image
Pro Image Analyzer software (version 4.5 for windows,
Media Cybernetics Inc., Silver Spring, MD, USA). The
ratio of the anterior and posterior heights of each vertebral
body was determined and a difference between the
anterior and posterior edges exceeding 20% was consid-
ered as a radiographic vertebral fracture. Information on
prevalent non-vertebral fractures (wrist, hip, humeral
fracture, rib, ankle, and foot) was collected during
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Grading of aorta calcification
AC was assessed on lateral radiographs. Briefly, calcified
deposits in the lumbar aorta adjacent to each lumbar
vertebra (L1–L4) were assessed separately for the
anterior and posterior wall of the aorta using the
midpoint of the inter-vertebral space as the boundaries.
Each wall of each segment was graded for the presence
of calcified deposits with a score from 0 to 3 (0: no
deposits, 1: less than one-third of the aortic wall, 2: one-
third to two-thirds of the aortic wall. 3: more than two-
thirds of the aortic wall covered with calcified deposits).
The sum of the scores of individual aortic segments both
for the anterior and posterior walls, termed as anterior-
posterior severity score and was used to describe the
overall severity of AC in the lumbar aorta. Maximum
score possibly given was 4×2×3=24. The same investi-
gator, who was blinded for all other results of the
individual participants, carried out the evaluations. Intra-
rater correlations between repeated measurements were in
the range of r=0.92–98 (n=50).
Laboratory parameters
Blood samples were collected in the morning after fasting
overnight (>12 h). Serum total cholesterol, triglyceride, and
high-density lipoprotein (HDL) cholesterol were deter-
mined by enzymatic assay using a Vitros-250 (Johnson &
Johnson, Taastrup, Denmark). LDL cholesterol was calcu-
lated by Friedewald formula (LDL−C=TC−HDL−C−
0.45×TG). Lipoprotein(a), ApoA1, and ApoB were mea-
sured by the Cobas Mira (Hoffman-La Roche, Mannheim,
Germany) automatic blood analyzer.
Genotyping
DNA was isolated from peripheral blood samples. ApoE
epsilon 2, epsilon 3 and epsilon 4 alleles were determined
by enzymatic amplification of genomic DNA followed by
restriction enzyme treatment of the amplified products
(Ossendorf and Prellwitz, Qiangen News 2000, issue1,
11–13). Briefly, amplified products were treated with AflII
and HaeII, respectively, and subjected to electrophoretic
separation in agarose gels. The sequences of the amplifica-
tion primers were 5’-ACTGACCCCGGTGGCGGAGGA
GACGCGTGC-3’ and 5’-TGTTCCACCAGGGGCCC
CAGGCGCTCGCGG-3’. One of these primers was delib-
erately designed with a mismatch (underlined) to create a
non-polymorphic AflIII site permitting assessment of the
efficiency of the digestion process.
Statistical analysis
Results are presented as mean±SD, unless otherwise
indicated. Confounders of hip BMD and AC were
identified by univariate correlation analysis. We classified
ApoE genotypes into two categories marked by absence or
presence of the ɛ4 allele. General linear models (GLM)
tested the differences in selected dependent variables after
adjustment for possible confounders. Similar approach was
used to identify factors showing differences between
women with or without fractures. Logistic regression
models were established to assess the age-dependent and
age-independent relative risk of wrist, hip, or vertebral
fractures in women with advanced aorta calcification or
cardiovascular disease. Statistical analyses were carried out
using the SPSS data analysis software (version 12, SPSS
Inc., Chicago, IL). All statistical tests were two-tailed and
differences were considered significant if the p-value was
less than 0.05.
Results
Demographic characteristics
Demographic characteristics of the total population are
shown in Table 1. Less than one fifth of the population with
an average age of 69.3 years had one or more manifes-
Table 1 Demographic characteristics in the study population
Characteristics and equivalent values
No. of women 1176
Age (years) 69.3±6.4
Age at menopause (years) 48.7±5.0
BMI (kg/m
2) 26.4±4.4
Current smoking (%) 24.6%
Regular intake of alcohol (%) 55.2%
Serum total cholesterol (mmol/l) 6.3±1.0
Serum triglyciders (mmol/l) 1.4±0.7
Serum HDL (mmol/l) 1.7±0.4
Serum LDL (mmol/l) 4.0±0.9
Serum ApoA1 (mmol/l) 203.9±37.1
Serum ApoB (mmol/l) 120.3±24.5
Serum Lp(a) (mmol/l) 31.9±34.6
ApoE ɛ4 allele carrier 367, 31.2%
Total hip BMD (g/cm
2) 0.80±0.1
Lumbar spine BMD (g/cm
2) 0.92±0.2
Hip BMD T-score ≤−2.5 (no. of women,%) 147, 12.5%
Spine BMD T-score ≤−2.5 (no. of women,%) 179, 15.2%
Vertebral fracture (no. of women, %) 204, 17.6%
Hip fracture (no. of women,%) 16, 1.4%
Aorta calcification 3.0±3.8
Cardiovascular disease (no. of women,%) 50, 4.3%
Data shown are mean±SD.
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or below −2.5 and/or a fracture. In terms of cardiovascular
status, the mean severity score of AC was 3.0±3.8 and the
number of women with history of an acute cardiovascular
event was 50 (4.3%).
The ApoE genotype frequencies were 0.9% (n=11) for
ApoE ɛ2-2, 12.7% (n=149) for ApoE ɛ2-3, 2.5% (n=29)
for ApoE ɛ2–4, 55.2% (n=649) for ApoE ɛ3–3, 26.6%
(n=313) for ApoE ɛ3–4, and 2.1% (n=25) for ApoE ɛ4–4,
respectively. When classifying ApoE genotypes into ab-
sence of ApoE ɛ4 allele and presence of ApoE ɛ4 allele,
31.2% (n=367) of women were ApoE ɛ4 allele carriers.
These genotype proportions did not deviate significantly
with those expected under conditions of Hardy-Weinberg
equilibrium (X
2=4.55; df=3; p=0.21), and they were
similar to those previously reported for Danish populations
[22, 23].
Correlates of hip and spine BMD and AC
In univariate analyses, summarized in Table 2, AC showed
direct correlation with age, CFM/PFM ratio, smoking,
treated hypertension, and inverse association with physical
exercise, regular alcohol consumption, BMI, and TFM%.
On the other hand, BMI, TFM% and CFM/PFM ratio were
significant direct, whereas age, years since menopause, and
smoking were inverse correlates of both spine and hip
BMD. Treated hypertension was significantly associated
with spine BMD, whereas the severity score of AC was a
significant inverse correlate of hip BMD (p<0.05).
The independent role of the ApoE ɛ 4 allele
Results of comparing lipids and lipoproteins between
women with or without the ApoE ɛ4 allele are summarized
in Table 3. After adjustment for confounders, women with
an ApoE ɛ4 allele had significantly higher serum total
cholesterol, triglycerides, LDL-C, and ApoB levels than
women without this allele. Furthermore, presence of the
ApoE ɛ4 allele was associated with significantly lower
HDL-C. In contrast, the differences in serum ApoA1 and
Lp(a) did not reach statistical significance (Table 3).
Finally, there were no significant differences in adjusted
spine or hip BMD or the severity of AC (p>0.05).
Associations of lipids with BMD and AC
In univariate analysis (Table 2), total cholesterol and
triglycerides were common correlates of spine BMD, hip
BMD, and AC. HDL-C and ApoA1 were common
correlates of AC and hip BMD (p<0.05), whereas LDL-C,
but not ApoB, was a common correlate of AC (p<0.05).
To obtain insights into the direct contribution of lipids to
the variation of hip and spine BMD and the severity of AC,
we established multiple regression models. The indepen-
dent contributors to the variation in these surrogate markers
are indicated in Table 2. Lipids were not independent
contributors to the variation in BMD when assessed in the
presence of the severity of AC and other confounders.
However, ApoA1 levels did seem to contribute to the
variation in AC.
Table 2 Independent corre-
lates of aorta calcification, hip
BMD, and spine BMD
(multiple regression models)
Excl.: excluded from the model
due to strong co-linearity.
Aorta Calcification Hip BMD Spine BMD
Age 0.35 (p<0.001) −0.23 (p<0.001) −0.03 (p=0.45)
YSM −0.06 (p=0.16) −0.06 (p=0.10) −0.08 (p=0.04)
BMI −0.09 (p=0.07) 0.48 (p<0.001) 0.45 (p<0.001)
TFM% −0.04 (p=0.36) −0.10 (p=0.04) −0.21 (p<0.001)
CFM/PFM ratio 0.08 (p=0.02) −0.004 (p=0.85) 0.05 (p=0.21)
Smoking 0.19 (p<0.001) −0.05 (p=0.10) −0.01 (p=0.66)
Exercise −0.03 (p=0.25) 0.04 (p=0.17) 0.04 (p=0.21)
Treated hypertension 0.08 (p=0.006) 0.006 (p=0.81) 0.05 (p=0.09)
Alcohol consumption −0.08 (p=0.007) 0.06 (p=0.04) 0.07 (p=0.02)
ApoE ɛ4 −0.009 (p=0.77) 0.01 (p=0.76) −0.03 (p=0.22)
Triglyceride 0.02 (p=0.63) 0.03 (p=0.43) 0.04 (p=0.32)
HDL-C 0.05 (p=0.48) −0.06 (p=0.29) 0.02 (p=0.74)
LDL-C Excl. 0.02 (p=0.73) −0.10 (p=0.10)
Total cholesterol 0.05 (p=0.43) Excl. Excl.
ApoA1 −0.10 (p=0.04) 0.05 (p=0.36) 0.05 (p=0.39)
ApoB 0.10 (p=0.14) −0.03 (p=0.60) 0.10 (p=0.85)
Aorta Calcification −0.09 (p=0.002) 0.04 (p=0.20)
R=0.44, SEE=3.32
P<0.001
R=0.55, SEE=0.09
P<0.001
R=0.34, SEE=0.13
P<0.001
508 Osteoporos Int (2007) 18:505–512Comparison of women with or without fractures
There were altogether 293 subjects who had an osteoporotic
fracture after the menopause (i.e., prevalent hip, vertebral,
or wrist fracture). Of the 204 women with at least one
vertebral fracture, 33 also had a history of wrist fracture and
16 reported a history of hip fracture. Prevalence of non-
vertebral fractures was significantly higher in women with
compared with those without vertebral fracture(s). Charac-
teristics of women with or without vertebral fractures are
summarized in Table 4. Women with fractures were on
average older and had a tendency for being physically less
active. However, no significant differences in BMI, body
adiposity, or body fat distribution were apparent. In
addition, no significant differences in a wide array of
lifestyle factors were apparent.
When comparing the lipid profile of women with or
without osteoporotic fractures after adjustment for potential
confounders (i.e., age, years since menopause, BMI, TFM%,
CFM/PFM ratio, smoking, ApoE ɛ4 allele, physical exercise,
alcohol consumption, and severity score of AC), only tri-
glycerides showed significant differences between the two
groups (p<0.05). Thus, triglycerides in women with and
without fractures were 1.31±0.04 mmol/l and 1.42±
0.03 mmol/l, respectively. When analyzing fracture types
separately, the difference between women with or without
hip or wrist fractures were not statistically significant.
The relative risk of hip or vertebral fracture in women
with severe AC or CVD
To assess the implications of atherosclerotic vascular
disease for osteoporotic fracture risk, we calculated the
odds ratio of the different types of fractures in women with
severe AC (≥6) and/or manifest CVD. As indicated in
Table 5, after adjustment for age, the risk of hip fractures
but not wrist or vertebral fractures was increased in subjects
with advanced vascular disease.
Table 4 Characteristics of women with or without at least one
vertebral fracture
Without
vertebral
fracture
With
vertebral
fracture
p-value
Age 68.9±6.4 71.3±6.4 <0.001
YSM 12.7±8.4 15.5±8.6 <0.001
BMI 26.4±4.4 26.3±4.4 NS
TFM% 41.3±7.6 40.7±7.8 NS
CFM/PFM ratio 0.88±0.23 0.90±0.24 NS
Regular exercise 73.8% 67.6% 0.08
ApoE ɛ4 allele + 30.5% 34.8% NS
Total cholesterol 6.32±1.00 6.31±1.04 NS
Triglycerides 1.42±0.69 1.31±0.54 0.02
HDL-C 1.68±0.43 1.71±0.39 NS
LDL-C 3.98±0.93 4.01±0.96 NS
ApoA1 203.8±37.8 204.6±33.4 NS
ApoB 120.6±24.5 119.1±24.5 NS
Lp(a) 31.7±34.9 32.5±33.5 NS
Spine BMD 0.93±0.15 0.87±0.14 <0.001
Hip BMD 0.82±0.11 0.75±0.11 <0.001
Hip fracture 1.0% 2.9% 0.04
Wrist fracture 11.4% 14.6% 0.04
AC score 2.8±3.7 3.5±3.4 0.03
CVD 3.6% 7.4% 0.02
There were no significant differences in the frequency of smoking,
regular alcohol, coffee, milk or seasonal vitamin D consumption, type
2 diabetes, treated hyperlipidemia or treated hypertension
Table 3 Lipid and bone profile in women with or without an ApoE
epsilon 4 allele
Absence
of ApoE
epsilon 4
allele
(n=809)
Presence
of ApoE
epsilon 4
allele
(n=367)
P value
Serum total cholersterol*
(mmol/l)
6.24±0.03 6.51±0.05 <0.001
Serum triglycides* (mmol/l) 1.36±0.02 1.48±0.03 0.005
Serum HDL* (mmol/l) 1.72±0.01 1.65±0.02 0.006
Serum LDL* (mmol/l) 3.91±0.03 4.19±0.05 <0.001
Serum ApoA1* (mmol/l) 205.8±1.3 201.3±2.0 0.06
Serum ApoB* (mmol/l) 117.3±0.8 127.2±1.3 <0.001
Serum Lp(a)* (mmol/l) 31.9±1.3 29.2±2.0 0.24
Total hip BMD (g/cm
2)* 0.803±0.004 0.804±0.005 0.89
Spine BMD (g/cm
2)* 0.924±0.005 0.915±0.008 0.32
Hip fracture 1.7% 0.5% 0.17
Vertebral fractures 16.4% 19.3% 0.24
Severity score of AC** 2.81±0.14 2.97±0.21 0.13
Cardiovascular disease 4.0% 4.9% 0.44
Values are mean±SEM.
*Adjustment for age, years since menopause, BMI, TFM%, CFM/
PFM ratio, current smoking, physical exercise, and regular
alcohol consumption.
**Adjustment for the aforementioned confounders + treated
hypertension.
Table 5 Relative risk of different types of osteoporotic fractures in
women with severe aorta calcification (score≥6) and/or manifest
cardiovascular disease (n=282)
Odds ratio
(95% CI)
p-value
Hip fracture
N=16
Crude 4.4 (1.6–12.9) 0.001
Age-adjusted 3.0 (1.1–8.8) 0.04
Vertebral fracture
N=204
Crude 1.2 (0.9–1.7) 0.27
Age-adjusted 1.0 (0.7–1.4) 0.93
Wrist fracture
N=145
Crude 1.4 (1.0–2.1) 0.06
Age-adjusted 1.2 (0.8–1.7) 0.46
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In the present study, we investigated whether serum lipid
and lipoproteins represent a biological linkage between
osteoporosis and cardiovascular disease. The main findings
were as follows: 1) neither allelic polymorphism in the
ApoE gene nor serum lipids per se were independent
correlates of BMD at any skeletal site, 2) ApoA1 levels
were independent correlates of AC, which seem to play a
role in the determination of hip BMD, 3) decreased
triglycerides were independently associated with vertebral
fractures, but not with non-vertebral fractures (hip and
wrist), and 4) advanced vascular disease was a significant
contributor to risk of hip fractures, but not to vertebral or
wrist fractures. These observations suggest that the role of
lipids as linking factors between cardiovascular disease and
osteoporosis is indirect via promotion of atherogenesis,
which in turn can contribute to bone loss, especially at
skeletal sites with end-arterial blood supply. Antiathero-
genic measures can also be expected to contribute to
decreasing the burden of hip fractures among the elderly.
Univariate analysis pointed out several common corre-
lates of BMD and atherosclerosis. Of these factors, aging,
the duration of the menopause, BMI, and TFM% seemed to
have reciprocal impact on BMD and AC. In multiple
regression models, whereas BMI continued to correlate
directly, TFM% became an inverse correlate of BMD.
Accordingly, while weight-bearing may have a favourable
impact on bone metabolism, adipose tissue accumulation
exert an adverse influence. These findings corroborate the
recent findings of Hsu YH et al. [24]. Although traditional
views considered obesity a protective factor due to
endogenous estrogen production, these more recent find-
ings emphasize that other factors deriving from adipose
tissue, e.g., adipokines, inflammatory cytokines, and per-
haps even lipids/lipoprotein metabolism are also to be taken
into account. In addition, these findings also draw attention
to the need of proper adjustment for overall adiposity and
body fat distribution when addressing the direct implication
of selected potential mediators.
To address whether serum lipids represent a biological
linkage between osteoporosis and vascular disease, one
approach is to investigate whether polymorphism in a gene
with known modulator effects on serum lipid profile is
associated with variation in the severity of AC and BMD.
Similar to previous observations [25, 26], we found that
presence of the ɛ4 variant allele in the ApoE gene was
independently associated with higher levels of total choles-
terol, LDL-C and ApoB. In addition, we also observed
subtle, yet statistically significant differences in serum
triglycerides and HDL-C levels. Nevertheless, we were
not able to document significant associations of the ɛ4
allele with either BMD or AC score. In male or mixed
populations, the ɛ4 allele was reported as a risk factor for
atherosclerosis [27, 28], suggesting that the association
might be gender-specific for males. Total cholesterol and
LDL-C are important predictors of cardiovascular risk in
men, but less so in postmenopausal women in whom
triglycerides and HDL-C carry greater importance [29, 30].
Another explanation to the apparent discrepancies could be
geographic variation in the relative importance of allelic
variation in the ApoE gene. In support, a study in Finnish
men reported higher importance of the ɛ3a l l e l ef o r
atherogenesis compared with the ɛ4 allele [27]. Similar
discrepancies exist concerning the relative importance of
this gene polymorphism for the determination of bone
mass. Although there are reports suggesting that presence
of the ɛ4 allele is a contributor to accelerated bone loss and/
or increased risk of osteoporotic fractures [31, 32], not all
studies confirm this finding, particularly those undertaken
in women [33–35]. Collectively, ApoE polymorphism with
primary influence on total cholesterol, LDL-C, and apoB
levels does not seem to provide a major biological linkage
between the pathogenesis of osteoporosis and CVD.
Experimental observations proposed LDL-C and HDL-C
as common modulators of bone cells and vascular smooth
muscle cells [11–14]. On the clinical side, smaller cross-
sectional studies found associations between lipid profile
and BMD [15–17]. However, none of these studies adjusted
systematically for a direct DEXA measure of body fat
distribution and/or smoking habits, which are important
confounders of lipid profile. Our multiple regression
analyses could not reveal significant independent associa-
tions of any of the considered lipid and lipoprotein
components with hip or spine BMD. These findings are in
line with the largest population-based observational study,
the NHAEMS III survey including more than 13,000
subjects [19]. In further support, a recent longitudinal
analysis of results from the Framingham study cohort
reported insignificant direct influence of serum lipids for
changes of BMD during a 25-year observational period
[18]. Collectively, these observations do not seem to
nurture the concept that serum lipids and lipoproteins exert
clinically detectable direct effects on bone mineralization in
elderly women.
To further assess the potential implications of serum
lipids and lipoproteins for osteoporosis, we also compared
the profile of postmenopausal women with or without
osteoporotic fractures. Interestingly, serum triglycerides
were significantly lower in women with at least one
vertebral fracture compared with those with no fractures,
while no differences were seen between those with or
without an osteoporotic non-vertebral fracture (i.e., hip or
wrist fracture). This finding is similar to that reported by
Yamaguchi et al. [15]. Since triglycerides were not
associated with spine BMD, their direct contribution to
510 Osteoporos Int (2007) 18:505–512fracture risk, if any, is via modulation of bone quality or
bone strength. Given the cross-sectional design of this
study, we cannot exclude the possibility that a confounder
or confounders of triglyceride levels, which was not
considered herein is the actual modulator of bone fragility
and hence fracture risk.
Important finding of the multiple regression analysis was
that the severity of AC was an independent correlate of hip
BMD with no simultaneous independent contribution of
lipids. This observation provides evidence that obstructive
vascular disease rather than lipids/lipoproteins per se that
drive bone loss from the hip. In a previous study, we
showed that women with intermittent claudication have not
only severe AC, but also very low BMD [2]. The direct
contribution of atherosclerosis is also supported by the
observation showing that asymmetric vascular disease is
accompanied by asymmetric demineralization of this
skeletal site [36]. Moreover, studies show that the rate of
demineralization at the hip is significantly associated with
the rate of atherogenesis [5] and even future risk of
cardiovascular events [37]. On the other hand, we recently
demonstrated in a large population-based cohort of post-
menopausal women that accelerated atherogenesis is an
independent predictor of hip fracture risk. Histological
investigations of explants from elderly patients with
femoral neck fractures indicate that both the larger
(a. iliaca ext and a. femoris profunda) and the small vessels
in the ligamentum teres supplying this skeletal site are
frequently obstructed by atheromatous lesions [38, 39].
These observations provide strong support for the important
role of atherosclerosis for the pathogenesis of osteoporosis
in the proximal femur.
In summary, the results of the present observational
study provide further evidence for the independent associ-
ation of peripheral vascular disease with osteoporosis in the
proximal femur. Since the association of lipids and lipo-
proteins to BMD and non-vertebral fractures is not
independent of the severity of AC, it seems unlikely that
these metabolites exert direct and clinically significant
effects on bone turnover in postmenopausal women. Their
contribution is via promotion of atherogenesis, in which
regard ApoA1 levels seem to take a leading role. The
remaining issue to be clarified is which genetic or
environmental factors underlie the association of low
triglycerides levels to vertebral fractures.
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